Adam Smith Conferences

Adam Smith Conferences Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Adam Smith Conferences, Republic of Kazakhstan, Almaty,st. Zharokova, d. 257, of. 201, Moscow.

A practical Panel Session on the Commercialization of Pharmaceutical Products, exploring how marketing and digital techn...
28/01/2026

A practical Panel Session on the Commercialization of Pharmaceutical Products, exploring how marketing and digital technologies are transforming pharma promotion — from online-offline integration and AI-driven personalization to digital channels (e-commerce, social media, mobile apps), CRM-based sales automation, and personalized engagement with doctors and pharmacies, while navigating advertising restrictions and personal data regulations.

MARINA DURMANOVA, President, Association for the Support and Development of Pharmaceutical Activities of the Republic of Kazakhstan
LARISSA YEMELYANOVA, Partner, AEQUITAS Law Firm
ZHANNA KUNEKBAYEVA, General Director, Sona-Pharm Kazakhstan
EVGENIY TIKHONOV, Head of Sales, Dazur KZ
ALEXANDER BEZBORODOV, Attorney-at-law, Partner, LL.M., ADVANT Beiten
IVAN MEDVEDEV, Executive Director, Apteka So Sklada

The second day of the Eurasian Pharmaceutical Forum began with one of the most relevant and timely sessions: an expert a...
28/01/2026

The second day of the Eurasian Pharmaceutical Forum began with one of the most relevant and timely sessions: an expert analytical panel on the EAEU pharmaceutical market.

The discussion covered key trends, challenges and growth areas, such as sales volumes and market share by product type (e.g. generics, innovative drugs and biologics), market growth forecasts up to 2027, comparisons with global trends, the impact of inflation and exchange rate fluctuations, changing consumer preferences and prospects for the pharmaceutical industry over the next 10 years.

EKATERINA MARKOVA, Director, Proxima Research Kazakhstan
TIMUR OTARSHINOV, Deputy Director of the Social Sector Department, Agency for Protection and Development of Competition of the Republic of Kazakhstan
EVGENIY ZEMLYANKIN, General Director, Amity International
NURZHAN OTARBAYEV, Chairman of the National Chamber of Health and the Committee on Pharmaceutical, Medical Industry, and Medical Services of Atameken
ZHIBEK KERIMBAYEVA, Country Head Kazakhstan & Eurasia, IQVIA
ELENA KORHOVA, Deputy Director for Commercial Affairs, Polmed
ANDREY KONOVALOV, General Director, ratiopharm Kazakhstan

A dynamic Panel Session on Modern Models of Intellectual Property Protection and Management in the Pharmaceutical Indust...
28/01/2026

A dynamic Panel Session on Modern Models of Intellectual Property Protection and Management in the Pharmaceutical Industry, covering patent protection strategies and early generic entry, data exclusivity, compulsory licensing and legal disputes in the EAEU, patenting specifics for innovative drugs, parallel import risks and opportunities, combating counterfeits, and Certificates of State Registration (CSR) for dietary supplements.

VADIM KUKAVA, Executive Director, Association of Pharmaceutical Companies "Pharmaceutical Innovations" ("InPharma")
OLZHAS SATYBALDIN, Head of Government Relations, Russia and Eurasia, AstraZeneca
ALEXEY KARTASHOV, Director for Public Relations, HimRar Group
ALEXANDER CHERNICHENKO, General Director, Muse Media
ARTEM EZHOV, Chief Expert of the Chemistry and Medicine Department of the Expertise Administration, Eurasian Patent Organization
AZAMAT HAMRAKULOV, Deputy Head of the Samarkand Territorial Department, Committee for Competition Development and Consumer Protection of the Republic of Uzbekistan
RAVIL KASSILGOV, Managing Partner, KP Disputes
YERZHAN ZHUNISOV, Deputy Director, QAZPATENT

Yesterday, a dynamic panel session on pricing and economic efficiency was held in the pharmaceutical industry. The sessi...
28/01/2026

Yesterday, a dynamic panel session on pricing and economic efficiency was held in the pharmaceutical industry. The session explored pricing models across the EAEU and CIS, high-cost therapy financing, the complexities of reference pricing, and pathways towards a unified pricing approach, all while balancing the interests of patients, the state and businesses.

VYACHESLAV LOKSHIN, President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan
YERLAN ALZHAN, Deputy Chairman, Agency for Protection and Development of Competition of the Republic of Kazakhstan
ZAFAR VAKHIDOV, Partner, Vakhidov & Partners
ANASTASIIA KINGSHOTT, Head of Department for Health Technology Assessment, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
VICTORIA VYUSHKOVA, Head of CIS, Astellas
ANDREY IVANOV, Head of Market Access Department, Kazakhstan, AstraZeneca
ANDREY KOLESNIKOV, Sr. Director of External Communications, Government Affairs & Market Access, Russia and Eurasia, Teva

An in-depth and forward-looking Panel Session on Medicine Registration in the Eurasian Region, focusing on the unificati...
27/01/2026

An in-depth and forward-looking Panel Session on Medicine Registration in the Eurasian Region, focusing on the unification of registration rules within the EAEU, current progress and remaining barriers, as well as national experiences in regulatory alignment.

The discussion covered simplified procedures for innovative and orphan drugs, recent changes in pharmacopoeial standards and their impact on quality, reduction of registration timelines through unified standards, and the implications of regulatory reforms for pharmaceutical supply chains.

We would like to thank our speakers for a rich and insightful dialogue.
Larisa Matveeva, Executive Director, Association of International Pharmaceutical Manufacturers
Elena Kovaleva, Director of the Center for Drug Quality Expertise, Scientific Center for Expertise of Medical Products, Ministry of Health of the Russian Federation
Azer Hasanov, Head of the Department of Drug Registration and Expertise, Analytical Expertise Center, Ministry of Health of the Republic of Azerbaijan
Saadat Sagyndykova, Head of the EAEU Sector, Department of Medicines and Medical Devices, Ministry of Health of the Kyrgyz Republic
Tatiana Vasilyeva, Head of Registration, Kazakhstan, AstraZeneca
Ardak Tulegenova, Chair of the EAEU Pharmacopoeia Committee
Uldan Derbisbekova, Head of the Department of Drug Expertise, National Center for Drug and Medical Device Expertise

The Plenary Session “State and Business: Creating Conditions for Industry Development” brought together government repre...
27/01/2026

The Plenary Session “State and Business: Creating Conditions for Industry Development” brought together government representatives and industry experts to discuss legislative changes, EAEU harmonization, localization and innovation support, investment climate improvements, and medicine supply across CIS countries.

We thank the moderator and speakers for a substantive and constructive dialogue on the future of the pharmaceutical sector.
Arevik Markaryan — Head of Strategic Sectors Department, Ministry of Economy of the Republic of Armenia
Elena Maksimkina — Director, Federal Center for Planning and Organization of Drug Provision for Citizens, Ministry of Health of the Russian Federation
Marat Kaliyev — International Expert, State Medical Insurance Fund of the Republic of Uzbekistan
Rafik Khudayev — Deputy Director General, Analytical Expertise Center, Ministry of Health of the Republic of Azerbaijan
Asel Esenalieva — Head of the Department of Drug Expertise, Department of Drugs and Medical Devices, Ministry of Health of the Kyrgyz Republic
Uldan Derbisbekova — Head of the Department of Drug Expertise, National Center for Drug and Medical Device Expertise

The discussion highlighted the importance of coordinated efforts between the state and business to create a sustainable, transparent, and innovation-driven pharmaceutical market across the region.

We have just concluded an open dialogue as part of the Plenary Discussion: “The Eurasian Pharma Market: The Industry’s V...
27/01/2026

We have just concluded an open dialogue as part of the Plenary Discussion: “The Eurasian Pharma Market: The Industry’s View on Challenges and Prospects”, held during Eurasian Pharma 2026.

Many of the questions raised continue to carry over from year to year — yet they clearly demand fresh approaches and new solutions. The discussion was candid, dynamic, and highly relevant to the realities facing the pharmaceutical industry across the region.

A sincere thank you to our outstanding speakers for their insights, expertise, and openness:

Moderator:
Vyacheslav Lokshin — President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan

Speakers:
Sofia Yatsko — Deputy Director for Public Relations and Market Access, GEROPHARM
Elena Lee — Founder of Dolce Group, President of AIID
Adilet Nazarbayev — General Director, Johnson & Johnson Kazakhstan
Zaituna Salmanova — Operations Director of Business Processes in the CauCAR region, Pfizer
Olzhas Satybaldin — Head of Government Relations, Russia and Eurasia, AstraZeneca
Pavel Khegay — General Director, Gedeon Richter Kazakhstan, Chairman of the Health Committee, EUROBAK

Thank you to everyone who contributed to this meaningful exchange. The conversation continues — and so does the search for practical, forward-looking solutions for the Eurasian pharmaceutical market.

The 17th International Eurasian Pharmaceutical Forum 2026 is structured around issues that have become central to the de...
09/01/2026

The 17th International Eurasian Pharmaceutical Forum 2026 is structured around issues that have become central to the development of the pharmaceutical market across Eurasia.

Regulation, innovation, pricing, intellectual property, supply chains, and access to medicines are no longer separate areas of discussion. Within the Forum agenda, these topics are considered as interconnected elements that collectively shape market stability, investment decisions, and patient outcomes.

The full programme is available via the link - https://eurasian-pharma.com/agenda

See you on 26–28 January in Almaty.

The EAEU pharmaceutical market is changing — and the right time to talk is now.On January 27, this conversation will tak...
08/01/2026

The EAEU pharmaceutical market is changing — and the right time to talk is now.

On January 27, this conversation will take place at the Eurasian Pharmaceutical Forum, during the plenary session “The Eurasian Pharma Market: The Industry’s View on Challenges and Prospects.”

The discussion will focus on market growth, production localization, regulatory requirements, and new opportunities emerging from public procurement liberalization.

The session will bring together executives representing R-Pharm, GEROPHARM, Johnson & Johnson, Nobel Almaty Pharmaceutical Factory, Pfizer, AstraZeneca, as well as the Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan.

We are looking forward to a practical, industry-driven exchange on the future of pharma in the EAEU region.

Details - https://eurasian-pharma.com/agenda

31/12/2025

Dear Colleagues,

As we look ahead to the New Year, we would like to thank you for your trust, collaboration, and the meaningful exchanges shared with Adam Smith Conferences throughout the year.

We hope the New Year brings you good health, clarity in decision-making, and new opportunities for growth — both professionally and personally.

Wishing you a happy, successful, and fulfilling New Year.

Adam Smith Conferences team
🎄🎁

25/12/2025

Merry Christmas from Adam Smith Conferences!

🎄 We wish you inspiration, confidence in every decision, and success in all your endeavors.
May your work bring satisfaction and happiness ✨

During the plenary discussion, industry experts will address the challenges and prospects of the Eurasian Pharma Market,...
16/12/2025

During the plenary discussion, industry experts will address the challenges and prospects of the Eurasian Pharma Market, production localization incentives and barriers, regulatory impact on business strategies, and new opportunities in public procurement.

The Eurasian Pharmaceutical Forum 2026 will be held on 26–28 January 2026 at the Swissôtel Alatau, Almaty, Kazakhstan.

eurasian-pharma.com

Address

Republic Of Kazakhstan, Almaty,st. Zharokova, D. 257, Of. 201
Moscow
050012

Telephone

+74957852208

Website

Alerts

Be the first to know and let us send you an email when Adam Smith Conferences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Adam Smith Conferences:

Shortcuts

Share